Sino Biological Inc(301047) : Citic Securities Company Limited(600030) special verification report on the deposit and use of raised funds in Sino Biological Inc(301047) 2021

Citic Securities Company Limited(600030)

About Sino Biological Inc(301047)

Special verification report on the deposit and use of raised funds in 2021

Citic Securities Company Limited(600030) (hereinafter referred to as ” Citic Securities Company Limited(600030) ” and “sponsor”) as the sponsor of Sino Biological Inc(301047) (hereinafter referred to as ” Sino Biological Inc(301047) ” and “company”) for initial public offering and listing on GEM, In accordance with the measures for the administration of securities issuance and listing recommendation business, the guidelines for the recommendation of listed companies of Shenzhen Stock Exchange, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for the standardized operation of GEM listed companies of Shenzhen Stock Exchange, and the guidance on the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies And other relevant regulations, performed continuous supervision duties, and conducted special verification on the storage and use of raised funds in Sino Biological Inc(301047) 2021. The verification results and verification opinions are as follows:

1、 Basic information of raised funds

According to the reply on Approving the registration of Sino Biological Inc(301047) initial public offering (zjxk [2021] No. 2364) issued by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) on July 13, 2021, the company issued 17 million ordinary shares (A shares) in RMB for the first time, with a par value of 1 yuan per share and an issue price of 292.92 yuan per share, The total amount of funds raised is 497964 million yuan, after deducting the issuance expenses (excluding tax) of 2558857 million yuan, the net amount of funds raised is 47237543 million yuan, of which the over raised funds are 38237543 million yuan. All the above raised funds have been in place, which have been verified by Zhitong Certified Public Accountants (special general partnership) and issued the capital verification report (ztyz (2021) No. 110c Digital China Information Service Company Ltd(000555) ) on August 9, 2021.

As of December 31, 2021, the accumulated funds raised by the company have directly invested 3679499 million yuan (including 250 million yuan of supplementary working capital), and the over raised funds have permanently supplemented 1145 million yuan of working capital, The unused amount is 31991291 million yuan (including 2861291 million yuan of raised funds deposited in the special account, 3154200 yuan of accumulated interest stored in the special account after deducting handling fees, and 2913 million yuan of financial management). The actual balance of raised funds is 31991326 million yuan, and the difference of 35000 yuan is the unpaid issuance fee.

2、 Deposit and management of raised funds

In order to standardize the management and use of raised funds and protect the rights and interests of investors, In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of Shenzhen Stock Exchange, the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies and other laws and regulations, and in combination with the actual situation of the company, The management measures for the raised funds of Beijing Sino Biological Inc(301047) Technology Co., Ltd. (hereinafter referred to as the “management measures”) was formulated, which was deliberated and adopted at the third meeting of the first board of directors in 2020.

According to the management measures and in combination with the business needs, the company implements a special account for the raised funds, which are stored in Bank Of Communications Co.Ltd(601328) Beijing Pilot Free Trade Zone sub branch of Bank Of Shanghai Co.Ltd(601229) Beijing Yizhuang sub branch of Bank Of Shanghai Co.Ltd(601229) Beijing Economic and Technological Development Zone sub branch of Industrial Bank Co., Ltd. Bank Of Beijing Co.Ltd(601169) economic and Technological Development Zone sub branch, Hua Xia Bank Co.Limited(600015) Beijing Shijingshan sub branch Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. Beijing Branch, Shanghai Pudong Development Bank Co.Ltd(600000) Beijing Zhichun Road sub branch, China Merchants Bank Co.Ltd(600036) Taizhou Branch set up special accounts for the use of raised funds, and signed the tripartite supervision agreement on raised funds with the deposit bank and the sponsor to strictly approve the use of raised funds to ensure that the special funds are used for special purposes.

As of December 31, 2021, the storage of raised funds is listed as follows:

Unit: 10000 yuan

Deposit bank account number account category storage balance

Bank Of Communications Co.Ltd(601328) Beijing Pilot free trade zone 11006077701 Fuan Pharmaceutical (Group) Co.Ltd(300194) 88 special deposit account 219865 sub branch 36

Bank Of Communications Co.Ltd(601328) Beijing Pilot free trade zone 110060777013 Sinosteel New Materials Co.Ltd(002057) 9 special deposit account 121.09 sub branch 03

Bank Of Shanghai Co.Ltd(601229) Beijing Yizhuang sub branch 0 Maccura Biotechnology Co.Ltd(300463) 1381 special deposit account 1511404

Bank Of Shanghai Co.Ltd(601229) Co., Ltd. Beijing Yizhuang sub branch 0 Guangdong Saca Precision Manufacturing Co.Ltd(300464) 7563 special deposit account 1004455

Industrial Bank Co.Ltd(601166) Beijing Economic and Technological Development 3211 Zhejiang Cayi Vacuum Container Co.Ltd(301004) 62355 special deposit account 1.67 faqu sub branch

Industrial Bank Co.Ltd(601166) Beijing Economic and Technological Development 3211 Zhejiang Cayi Vacuum Container Co.Ltd(301004) 64192 special deposit account 22.51 faqu sub branch

Bank Of Beijing Co.Ltd(601169) economic and Technological Development Zone 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 61470004897 special deposit account 33.02 sub branch 5082

Hua Xia Bank Co.Limited(600015) Beijing Shijingshan sub branch 10270 China Union Holdings Ltd(000036) 44557 special deposit account 47.27

Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. Beijing Branch 11010401 Wuhan East Lake High Technology Group Co.Ltd(600133) 540 special deposit account 22.68

Shanghai Pudong Development Bank Co.Ltd(600000) Beijing Zhi 91170078801 China Vanke Co.Ltd(000002) 04 special deposit account 26.26 Chunlu sub branch 6

Deposit bank account number account category storage balance

China Merchants Bank Co.Ltd(600036) Taizhou Branch 523901337310118 special deposit account 981.52

Total 2861326

Among the above deposit balances, the interest income of 3.155 million yuan has been included in the special account for raised funds (including 3.155 million yuan of interest income in 2021), the handling fee of 0700 yuan has been deducted (including 0700 yuan of handling fee in 2021), and the issuance fee that has not been paid from the special account for raised funds is 35000 yuan.

3、 Actual use of raised funds in 2021

In 2021, the actual use of the company’s raised funds is as follows:

(I) use of funds for investment projects with raised funds

As of December 31, 2021, please refer to the attached table comparison table of the use of raised funds in 2021 for the use of funds of the company’s investment projects with raised funds in 2021.

(II) early investment and replacement of raised investment projects

The company held the 11th meeting of the first board of directors and the 10th meeting of the first board of supervisors on September 13, 2021, deliberated and adopted the proposal on using raised funds to replace self raised funds for pre invested projects and paid issuance expenses, which was deliberated and adopted at the second extraordinary general meeting of shareholders in 2021 on September 30, 2021, It is agreed that the company will use the raised funds of this issuance to replace the self owned funds invested in the raised investment projects in advance and the paid issuance expenses, totaling 903841 million yuan. The independent directors of the company have expressed their independent opinions on the above matters. Grant Thornton Certified Public Accountants (special general partnership) conducted special verification on the above matters of self raised funds invested in advance by replacement, and issued the verification report on the investment projects invested by Beijing Sino Biological Inc(301047) Technology Co., Ltd. with self raised funds in advance and the paid issuance expenses (ztzz (2021) No. 110a015932), The recommendation institution issued verification opinions.

(III) temporary replenishment of working capital with idle raised funds

As of December 31, 2021, the company did not temporarily supplement working capital with idle raised funds.

(IV) cash management of idle raised funds and investment in related products

On September 13, 2021, the company held the 11th meeting of the first board of directors and the 10th meeting of the first board of supervisors, deliberated and approved the proposal on using part of the temporarily idle raised funds for cash management, and agreed that the company would use the temporarily idle raised funds (including over raised funds) with a total amount of no more than RMB 320 million for cash management, On September 30, 2021, after the deliberation and approval of the second extraordinary general meeting of shareholders in 2021, the company restricted the cash management of raised funds from investing in financial products with high safety and good liquidity. The service life is 12 months from the date of deliberation and approval of the general meeting of shareholders of the company. The above amount can be recycled within the validity period.

As of December 31, 2021, the balance of financial products purchased with raised funds is listed as follows:

Unit: 10000 yuan

Bank name product name product type transaction date subscription balance

Bank Of Beijing Co.Ltd(601169) Bank Of Beijing Co.Ltd(601169) economic and Technological Development breakeven fixed 202110-184000000 economic and Technological Development Zone sub branch seven day notice deposit income

Hua Xia Bank Co.Limited(600015) Bank Of Hangzhou Co.Ltd(600926) breakeven fixed 202110-139000000 Beijing Shijingshan sub branch Beijing Branch corporate notification account income

Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. North Hua Xia Bank Co.Limited(600015) breakeven fixed assets

Beijing Branch Beijing Shijingshan sub branch qitiantong income 202110-184000000 deposit

Shanghai Pudong Development Bank Co., Ltd. Wenli 21jg7980 guaranteed floating

Beijing Zhichun Road Branch Co., Ltd. (bullish on the third floor) revenue line 5000000 on October 13, 2021

Bank Of Communications Co.Ltd(601328) Bank Of Communications Co.Ltd(601328) Yuntong wealth regular Principal Guaranteed floating

Beijing Pilot Free Trade Zone sub branch structured deposit for 95 days (yellow income 4130000 gold linked bearish on October 14, 2021)

Industrial Bank Co.Ltd(601166) Industrial Bank Co.Ltd(601166) enterprise finance people’s guaranteed floating

Beijing Economic and Technological Development Zone Branch currency structured deposit product income 202110-11 line 3000000

Total 29130000

(V) permanent replenishment of working capital or repayment of bank loans with over raised funds

The company held the 11th meeting of the first board of directors and the 10th meeting of the first board of supervisors on September 13, 2021, deliberated and adopted the proposal on using some over raised funds to permanently supplement working capital, which was deliberated and adopted at the second extraordinary general meeting of shareholders in 2021 on September 30, 2021, It is agreed that the company will use part of the over raised funds of RMB 1145 million to permanently supplement the working capital, accounting for 29.94% of the total over raised funds. The permanent replenishment of working capital with over raised funds this time will not affect the capital demand of the project construction invested by the raised funds. No high-risk investment or financial assistance will be provided to others within 12 months after the replenishment of working capital. As of December 31, 2021, the company has permanently replenished working capital with over raised capital of RMB 1145 million.

As of December 31, 2021, the company did not repay bank loans with over raised funds.

(VI) use of over raised funds for projects under construction and new projects (including acquisition of assets, etc.)

As of December 31, 2021, the company has not used the over raised funds for projects under construction and new projects (including the acquisition of assets, etc.).

(VII) use of surplus raised funds

As of December 31, 2021, the company’s investment projects with raised funds have not been completed

- Advertisment -